header

Choose your language: Japanese Korean Traditional Chinese Simplified Chinese
IBC's 19th Annual International Conference
Antibody Engineering December 7-11, 2008 - Sheraton San Diego Hotel and Marina - San Diego, California
Antibody Engineering and Immunotherapeutics for the 21st Century

Scientific Sponsor

Market Research Reports

Antibody Engineering:
December 7-11, 2008 - Sheraton San Diego Hotel and Marina - San Diego, California

Since Antibody Engineering was first held in 1990 it has become the hallmark event of the field. During the five days of the conference(s), an unparalleled international faculty of more than 100 leading scientists will present their latest research results on advances in basic and applied antibody engineering, and the development of related antibody therapeutics.

Keynote Presentations

Evolving Technologies of Antibody Engineering
Michael L. Neuberger, Ph.D., Head, Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, United Kingdom
Antibodies: Versatile Proteins for Multiple Applications
Sherie Morrison, Ph.D., Chair, Department of Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles

Cutting-Edge Presentations from a Preeminent Internationally Recognized Faculty

  • Microarrays and Nanotechnology for Antibody Discovery and Analysis
  • The Single-Chain Fv and its Fusion Proteins: 20 Years Old and Coming of Age
  • The Theory, Practice and Use of Libraries Based on Restricted Amino Acid Sets
  • Are Non-Antibody Scaffolds Really any Better than Antibody Fragments?
  • Intrabodies Revisited
  • Novel Antibody Targets and Applications
  • Antibodies in a Complex Environment: Target Selection in Relation to Efficacy
  • Mechanism of Antibody Action Revisited

As an attendee for the Antibody Engineering meeting, you may also attend the sessions of the 6th Annual Antibody Therapeutics conference at no additional charge. This three-day program runs concurrent with Antibody Engineering from Tuesday-Thursday (December 9-11), and presentations feature over twenty updates on clinical and preclinical stage industry antibody programs, business and legal updates and much more!

Holding these two events together allows you to move freely among the sessions of both events and customize your conference experience to meet the needs of you and your organization. This unique meeting provides you with networking opportunities not available at any other antibody conference. Participants may network with more than 700 colleagues, explore exhibits showcasing new research technologies, and interact with speakers as well as poster authors.

footer

IBC LifeSciences
Copyright IBC Life Sciences, a part of Informa Life Sciences Group
Global Information, Inc. - International Marketing Partner of IBC LifeSciences.